Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GALVmed, Hester to accelerate delivery of livestock vaccines in India

The Global Alliance for Livestock Veterinary Medicines (GALVmed) has signed an agreement to accelerate vaccination of livestock against peste des petit ruminants (PRR) and Newcastle disease in India.

Alongside Indian veterinary vaccine specialist Hester Biosciences, the livestock health charity entered a partnership with Bihar Rural Livelihoods Promotion Society (BRLPS) to increase vaccination levels for the two diseases in the state of Bihar, India.

The Hester-GALVmed partnership is developing a consistent and maintainable supply of veterinary vaccines and health products in Bihar and Uttar Pradesh in Nepal.

The partnership will support BRLPS in training vaccinators and suppling them with cold chain-maintained vaccines alongside animal health and nutritional products at block level in Bihar. In return, BRLPS will be accountable for the selection of animal health workers to be trained, awareness creation among livestock owners and vaccination/service delivery in project zones.

GALVmed stated it envisages up to 500 new animal health workers to be trained to vaccinate goats against PPR and poultry against Newcastle disease. The organization also stated trained vaccinators will be provided with cool boxes to deliver the vaccines safely. Additionally, more than 20 new stock and retail distribution centers for vaccines and other healthcare products will be established. Training of staff involved in the project of preventive health care will receive ongoing training as the project continues.

GALVmed has also recently focused on advancing vaccine projects in Africa. It received $10 million in funding in September 2018 from the UK government's Department for International Development to develop seven new vaccines for neglected tropical diseases. 

Topics

What to read next

UsernamePublicRestriction

Register

AP015161

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel